Variables | Pre COVID-19 period (n = 2713) | During COVID-19 period (n = 948) | P | Effect size | ||
---|---|---|---|---|---|---|
n | Mean + SD | n | Mean + SD | |||
Age | 2713 | 61.77 ± 10.98 | 948 | 61.73 ± 11.01 | 0.926 | 0.00 |
Total comorbidities | 2713 | 4.84 ± 2.21 | 948 | 4.78 ± 2.22 | 0.514 | 0.03 |
Weight | 2591 | 86.60 ± 20.09 | 876 | 85.62 ± 19.96 | 0.212 | 0.05 |
HADS anxiety score measurement | 2711 | 9.24 ± 4.79 | 947 | 8.79 ± 4.78 | 0.013 | 0.09 |
 |  | % |  | % |  |  |
Gender female % | 987 | 36.3 | 347 | 36.8 | 0.758 | 0.01 |
Comorbid anxiety (yes) % | 1482 | 54.6 | 497 | 52.4 | 0.242 | 0.02 |
150Â min. physical activity a week (yes) % | 1019 | 40.8 | 339 | 39.8 | 0.612 | 0.01 |
Smoking (yes) % | 377 | 14.2 | 130 | 14.3 | 0.927 | 0.00 |
Partnered % | 1445 | 65.7 | 478 | 63.1 | 0.197 | 0.02 |
IMD (most deprived) % | 461 | 21.9 | 172 | 22.6 | 0.698 | 0.01 |